TRVI
Trevi Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Jennifer L. Good
IPO Date
2019-05-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Trevi Therapeutics, Inc.
CEO
Jennifer L. Good
IPO Date
2019-05-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US